UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 4, 2015
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 000-01649
NEWPORT CORPORATION
(Exact name of registrant as specified in its charter)
Nevada |
|
94-0849175 |
(State or other jurisdiction of |
|
(IRS Employer Identification No.) |
incorporation or organization) |
|
|
1791 Deere Avenue, Irvine, California 92606
(Address of principal executive offices) (Zip Code)
(949) 863-3144
(Registrants telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
x |
Accelerated filer o |
|
Non-accelerated filer |
o |
(Do not check if a smaller reporting company) |
Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x
As of July 31, 2015, 39,580,534 shares of the registrants sole class of common stock were outstanding.
NEWPORT CORPORATION
FORM 10-Q
PART I FINANCIAL INFORMATION
NEWPORT CORPORATION
Consolidated Statements of Income and Comprehensive Income
(In thousands, except per share data)
(Unaudited)
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
|
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
| ||||
|
|
2015 |
|
2014 |
|
2015 |
|
2014 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net sales |
|
$ |
147,977 |
|
$ |
153,232 |
|
$ |
304,632 |
|
$ |
300,122 |
|
Cost of sales |
|
84,058 |
|
83,344 |
|
170,432 |
|
164,775 |
| ||||
Gross profit |
|
63,919 |
|
69,888 |
|
134,200 |
|
135,347 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Selling, general and administrative expenses |
|
38,690 |
|
42,085 |
|
79,299 |
|
81,291 |
| ||||
Research and development expense |
|
15,158 |
|
14,318 |
|
30,113 |
|
28,456 |
| ||||
Loss (gain) on sale or other disposal of assets, net |
|
|
|
|
|
1,088 |
|
(411 |
) | ||||
Operating income |
|
10,071 |
|
13,485 |
|
23,700 |
|
26,011 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Interest and other expense, net |
|
(1,064 |
) |
(658 |
) |
(1,967 |
) |
(1,634 |
) | ||||
Income before income taxes |
|
9,007 |
|
12,827 |
|
21,733 |
|
24,377 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Income tax provision |
|
3,237 |
|
3,830 |
|
7,299 |
|
7,439 |
| ||||
Net income |
|
5,770 |
|
8,997 |
|
14,434 |
|
16,938 |
| ||||
Net income attributable to non-controlling interests |
|
|
|
45 |
|
|
|
100 |
| ||||
Net income attributable to Newport Corporation |
|
$ |
5,770 |
|
$ |
8,952 |
|
$ |
14,434 |
|
$ |
16,838 |
|
|
|
|
|
|
|
|
|
|
| ||||
Net income |
|
$ |
5,770 |
|
$ |
8,997 |
|
$ |
14,434 |
|
$ |
16,938 |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
| ||||
Foreign currency translation gains (losses) |
|
248 |
|
(825 |
) |
(5,963 |
) |
(364 |
) | ||||
Unrecognized net pension (losses) gains, net of tax |
|
(41 |
) |
59 |
|
429 |
|
102 |
| ||||
Unrealized losses on investments and marketable securities, net of tax |
|
(1 |
) |
(42 |
) |
(109 |
) |
(22 |
) | ||||
Other comprehensive income (loss) |
|
206 |
|
(808 |
) |
(5,643 |
) |
(284 |
) | ||||
Comprehensive income |
|
$ |
5,976 |
|
$ |
8,189 |
|
$ |
8,791 |
|
$ |
16,654 |
|
|
|
|
|
|
|
|
|
|
| ||||
Comprehensive income attributable to non-controlling interests |
|
$ |
|
|
$ |
46 |
|
$ |
|
|
$ |
115 |
|
Comprehensive income attributable to Newport Corporation |
|
5,976 |
|
8,143 |
|
8,791 |
|
16,539 |
| ||||
Comprehensive income |
|
$ |
5,976 |
|
$ |
8,189 |
|
$ |
8,791 |
|
$ |
16,654 |
|
|
|
|
|
|
|
|
|
|
| ||||
Net income per share attributable to Newport Corporation: |
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
0.15 |
|
$ |
0.22 |
|
$ |
0.36 |
|
$ |
0.42 |
|
Diluted |
|
$ |
0.14 |
|
$ |
0.22 |
|
$ |
0.36 |
|
$ |
0.42 |
|
|
|
|
|
|
|
|
|
|
| ||||
Shares used in per share calculations: |
|
|
|
|
|
|
|
|
| ||||
Basic |
|
39,717 |
|
39,881 |
|
39,659 |
|
39,703 |
| ||||
Diluted |
|
40,265 |
|
40,528 |
|
40,412 |
|
40,513 |
|
The accompanying notes are an integral part of these financial statements.
NEWPORT CORPORATION
(In thousands, except share and per share data)
(Unaudited)
|
|
July 4, |
|
January 3, |
| ||
|
|
2015 |
|
2015 |
| ||
ASSETS |
|
|
|
|
| ||
Current assets: |
|
|
|
|
| ||
Cash and cash equivalents |
|
$ |
39,717 |
|
$ |
46,883 |
|
Restricted cash |
|
1,259 |
|
1,704 |
| ||
Marketable securities |
|
6 |
|
57 |
| ||
Accounts receivable, net of allowance for doubtful accounts of $1,199 and $1,242 as of July 4, 2015 and January 3, 2015, respectively |
|
93,638 |
|
96,512 |
| ||
Inventories |
|
125,208 |
|
112,440 |
| ||
Current deferred tax assets |
|
20,764 |
|
20,734 |
| ||
Prepaid expenses and other current assets |
|
20,087 |
|
14,948 |
| ||
Total current assets |
|
300,679 |
|
293,278 |
| ||
|
|
|
|
|
| ||
Property and equipment, net |
|
83,211 |
|
82,793 |
| ||
Goodwill |
|
103,749 |
|
97,524 |
| ||
Long-term deferred tax assets |
|
5,679 |
|
5,005 |
| ||
Intangible assets, net |
|
70,271 |
|
70,811 |
| ||
Investments and other assets |
|
28,956 |
|
30,516 |
| ||
Total assets |
|
$ |
592,545 |
|
$ |
579,927 |
|
|
|
|
|
|
| ||
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
| ||
Current liabilities: |
|
|
|
|
| ||
Short-term borrowings |
|
$ |
4,084 |
|
$ |
3,772 |
|
Accounts payable |
|
36,574 |
|
31,448 |
| ||
Accrued payroll and related expenses |
|
33,227 |
|
34,607 |
| ||
Accrued expenses and other current liabilities |
|
32,140 |
|
31,797 |
| ||
Total current liabilities |
|
106,025 |
|
101,624 |
| ||
|
|
|
|
|
| ||
Long-term debt |
|
76,256 |
|
71,000 |
| ||
Pension liabilities |
|
29,351 |
|
28,554 |
| ||
Long-term deferred tax liabilities |
|
14,274 |
|
14,272 |
| ||
Other long-term liabilities |
|
7,369 |
|
7,773 |
| ||
|
|
|
|
|
| ||
Commitments and contingencies |
|
|
|
|
| ||
|
|
|
|
|
| ||
Stockholders equity: |
|
|
|
|
| ||
Common stock, par value $0.1167 per share, 200,000,000 shares authorized; 39,580,190 and 39,603,662 shares issued and outstanding as of July 4, 2015 and January 3, 2015, respectively |
|
4,623 |
|
4,626 |
| ||
Capital in excess of par value |
|
462,353 |
|
468,575 |
| ||
Accumulated other comprehensive loss |
|
(23,625 |
) |
(17,982 |
) | ||
Accumulated deficit |
|
(84,081 |
) |
(98,515 |
) | ||
Total stockholders equity |
|
359,270 |
|
356,704 |
| ||
Total liabilities and stockholders equity |
|
$ |
592,545 |
|
$ |
579,927 |
|
The accompanying notes are an integral part of these financial statements.
NEWPORT CORPORATION
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
|
Six Months Ended |
| ||||
|
|
July 4, |
|
June 28, |
| ||
|
|
2015 |
|
2014 |
| ||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
| ||
Net income |
|
$ |
14,434 |
|
$ |
16,938 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
| ||
Depreciation and amortization |
|
14,166 |
|
14,312 |
| ||
Gain on sale of assets |
|
|
|
(411 |
) | ||
Provision for losses on inventories |
|
3,706 |
|
2,439 |
| ||
Stock-based compensation expense |
|
6,827 |
|
5,447 |
| ||
Provision for doubtful accounts |
|
126 |
|
264 |
| ||
Loss on disposal of property and equipment |
|
1,153 |
|
287 |
| ||
Deferred income taxes |
|
(666 |
) |
(577 |
) | ||
Excess tax benefits from stock-based compensation |
|
(1,848 |
) |
(2,625 |
) | ||
Increase (decrease) in cash, net of acquisition and divestiture, due to changes in: |
|
|
|
|
| ||
Accounts receivable |
|
3,108 |
|
(3,985 |
) | ||
Inventories |
|
(15,349 |
) |
(13,277 |
) | ||
Prepaid expenses and other assets |
|
(3,022 |
) |
(2,602 |
) | ||
Accounts payable |
|
2,315 |
|
6,204 |
| ||
Accrued payroll and related expenses |
|
(2,107 |
) |
8,241 |
| ||
Accrued expenses and other liabilities |
|
2,328 |
|
3,946 |
| ||
Other long-term liabilities |
|
471 |
|
(999 |
) | ||
Net cash provided by operating activities |
|
25,642 |
|
33,602 |
| ||
|
|
|
|
|
| ||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
| ||
Purchase of property and equipment |
|
(10,135 |
) |
(11,895 |
) | ||
Restricted cash |
|
384 |
|
582 |
| ||
Proceeds from divestiture of business |
|
|
|
5,030 |
| ||
Acquisition of business, net of cash acquired |
|
(7,865 |
) |
|
| ||
Refundable amounts related to acquisition of a business |
|
(2,319 |
) |
|
| ||
Purchase of investments and marketable securities |
|
(824 |
) |
(661 |
) | ||
Proceeds from the sale or maturity of investments and marketable securities |
|
123 |
|
392 |
| ||
Net cash used in investing activities |
|
(20,636 |
) |
(6,552 |
) | ||
|
|
|
|
|
| ||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
| ||
Proceeds from long-term debt |
|
11,000 |
|
|
| ||
Repayment of long-term debt and obligations under capital leases |
|
(6,008 |
) |
(15,496 |
) | ||
Proceeds from short-term borrowings |
|
1,358 |
|
5,430 |
| ||
Repayment of short-term borrowings |
|
(4,971 |
) |
(3,613 |
) | ||
Purchases of non-controlling interests |
|
|
|
(1,863 |
) | ||
Proceeds from the issuance of common stock under employee plans |
|
1,075 |
|
2,642 |
| ||
Tax withholding payments related to net share settlement of equity awards |
|
(3,419 |
) |
(2,922 |
) | ||
Purchases of the Companys common stock |
|
(12,149 |
) |
|
| ||
Excess tax benefits from stock-based compensation |
|
1,848 |
|
2,625 |
| ||
Net cash used in financing activities |
|
(11,266 |
) |
(13,197 |
) | ||
Impact of foreign exchange rate changes on cash balances |
|
(906 |
) |
333 |
| ||
Net (decrease) increase in cash and cash equivalents |
|
(7,166 |
) |
14,186 |
| ||
Cash and cash equivalents at beginning of period |
|
46,883 |
|
53,710 |
| ||
Cash and cash equivalents at end of period |
|
$ |
39,717 |
|
$ |
67,896 |
|
|
|
|
|
|
| ||
Supplemental disclosures of cash flow information: |
|
|
|
|
| ||
Cash paid during the period for interest |
|
$ |
969 |
|
$ |
1,032 |
|
Cash paid during the period for income taxes, net |
|
$ |
6,310 |
|
$ |
3,935 |
|
Property and equipment accrued in accounts payable |
|
$ |
198 |
|
$ |
708 |
|
The accompanying notes are an integral part of these financial statements.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
NOTE 1 BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements include the accounts of Newport Corporation and its subsidiaries (collectively referred to as the Company) and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions of Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal and recurring accruals) considered necessary for a fair presentation have been included. All intercompany transactions and balances have been eliminated in consolidation.
The accompanying unaudited consolidated financial statements do not include certain footnotes and financial presentations normally required under generally accepted accounting principles (GAAP) and, therefore, should be read in conjunction with the consolidated financial statements and related notes contained in the Companys Annual Report on Form 10-K for the year ended January 3, 2015. The results for the interim periods are not necessarily indicative of the results the Company will have for the full year ending January 2, 2016. The January 3, 2015 balances reported herein are derived from the audited consolidated financial statements included in the Companys Annual Report on Form 10-K for the year ended January 3, 2015.
NOTE 2 RECENT ACCOUNTING PRONOUNCEMENTS
In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which created Topic 606. ASU No. 2014-09 establishes a core principle that a company should recognize revenue to depict the transfer of promised goods or services to a customer in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In order to achieve that core principle, companies are required to apply the following steps: (1) identify the contract with the customer; (2) identify performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the company satisfies a performance obligation. Upon adoption, ASU No. 2014-09 can be applied either (i) retrospectively to each prior reporting period or (ii) retrospectively with the cumulative effect of initial application recognized on the date of adoption. At the time of issuance, ASU No. 2014-09 was to become effective for interim and annual periods beginning after December 15, 2016, and early adoption was not permitted. However, in July 2015, the FASB deferred the effective date of ASU No. 2014-09 by one year to annual reporting periods beginning after December 15, 2017. In addition, early adoption of the standard will be permitted, but not before the original effective date of December 15, 2016. The Company is currently evaluating the expected impact of ASU No. 2014-09 on its financial position and results of operations.
In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory. ASU No. 2015-11 clarifies that inventory should be held at the lower of cost or net realizable value. Net realizable value is defined as the estimated selling price, less the estimated costs to complete, dispose and transport such inventory. ASU No. 2015-11 will be effective for fiscal years and interim periods beginning after December 15, 2016. ASU No. 2015-11 is required to be applied prospectively and early adoption is permitted. The Companys adoption of ASU No. 2015-11 is not expected to have a material impact on the Companys financial position or results of operations.
NOTE 3 ACQUISITION OF FEMTOLASERS
On February 11, 2015, the Company acquired all of the capital stock of FEMTOLASERS Produktions GmbH (FEMTOLASERS). The initial purchase price of 9.1 million was paid in cash at closing and is subject to a net asset adjustment. Based on the preliminary financial information provided by FEMTOLASERS, the Company estimated an initial net asset adjustment to the purchase price of approximately 1.6 million during the first quarter of 2015. Based on additional information obtained during the second quarter, the Company estimated a revised net asset adjustment of 2.1 million, resulting in a purchase price of 7.0 million (approximately $7.9 million). The final amount of this net asset adjustment is subject to agreement between the Company and the FEMTOLASERS selling shareholders, which the Company expects to finalize during the second half of 2015. Of the initial purchase price, 2.3 million was deposited at closing into escrow until thirty months after closing, to secure certain obligations of the FEMTOLASERS selling shareholders under the share purchase agreement, including the net asset adjustment. The Company incurred $0.4 million in transaction costs, which have been expensed as incurred and are included in selling, general and administrative expenses in the statements of income and comprehensive income. FEMTOLASERS expands the Companys offering of ultrafast laser products and enhances its technology base in this area. The results of FEMTOLASERS have been included in the results of the Companys Lasers Group as of the acquisition date.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
Immediately following the closing of the acquisition, the Company repaid 3.6 million (approximately $4.0 million) of FEMTOLASERS outstanding loans that were assumed as part of the acquisition.
The consideration paid by the Company for the acquisition of FEMTOLASERS is allocated to the assets acquired, net of the liabilities assumed, based upon their estimated fair values as of the date of the acquisition. The excess of the purchase price over the estimated fair value of the assets acquired, net of the estimated fair value of the liabilities assumed, is recorded as goodwill. The Company had made an estimated allocation of the purchase price in the first quarter of 2015. Based on additional information obtained during the second quarter of 2015, the Company refined the values assigned to assets, liabilities and the amount of goodwill. The second quarter adjustments in the table below were not material and therefore, they were recorded in the second quarter rather than retroactively. As discussed above, the Company has not yet finalized the purchase price. Any changes during the measurement period may have a further impact on goodwill.
(In thousands) |
|
Estimated |
|
Second |
|
Current |
| |||
Assets acquired and liabilities assumed: |
|
|
|
|
|
|
| |||
Cash |
|
$ |
78 |
|
$ |
|
|
$ |
78 |
|
Accounts receivable |
|
2,007 |
|
(39 |
) |
1,968 |
| |||
Inventories |
|
2,315 |
|
444 |
|
2,759 |
| |||
Deferred tax assets |
|
596 |
|
423 |
|
1,019 |
| |||
Other assets |
|
2,057 |
|
(42 |
) |
2,015 |
| |||
Goodwill |
|
7,841 |
|
(1,160 |
) |
6,681 |
| |||
Developed technology |
|
1,811 |
|
|
|
1,811 |
| |||
In-process research and development |
|
1,664 |
|
57 |
|
1,721 |
| |||
Other intangible assets |
|
543 |
|
|
|
543 |
| |||
Accounts payable |
|
(3,417 |
) |
|
|
(3,417 |
) | |||
Debt |
|
(4,021 |
) |
|
|
(4,021 |
) | |||
Deferred tax liabilities |
|
(1,005 |
) |
(14 |
) |
(1,019 |
) | |||
Other liabilities |
|
(1,974 |
) |
(221 |
) |
(2,195 |
) | |||
|
|
$ |
8,495 |
|
$ |
(552 |
) |
$ |
7,943 |
|
The goodwill related to the acquisition of FEMTOLASERS has been allocated to the Companys Lasers Group and will not be deductible for tax purposes.
The actual net sales and net loss of FEMTOLASERS from February 11, 2015, the closing date of the acquisition, that were included in the Companys consolidated statements of income and comprehensive income for the three and six months ended July 4, 2015, are set forth in the table below. Also set forth in the table below are the pro forma net sales and net income of the Company during the three and six months ended July 4, 2015 and June 28, 2014, including the results of FEMTOLASERS as though the acquisition had occurred at the beginning of 2014. This supplemental pro forma financial information is presented for information purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had occurred as of the beginning of 2014.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
|
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
| ||||
(Unaudited, in thousands) |
|
2015 |
|
2014 |
|
2015 |
|
2014 |
| ||||
Actual: |
|
|
|
|
|
|
|
|
| ||||
Net sales |
|
$ |
1,973 |
|
$ |
|
|
$ |
2,323 |
|
$ |
|
|
Net loss attributable to Newport Corporation |
|
$ |
(1,359 |
) |
$ |
|
|
$ |
(1,819 |
) |
$ |
|
|
Supplemental pro forma information: |
|
|
|
|
|
|
|
|
| ||||
Net sales |
|
$ |
147,977 |
|
$ |
156,571 |
|
$ |
304,901 |
|
$ |
305,678 |
|
Net income attributable to Newport Corporation |
|
$ |
6,146 |
|
$ |
8,865 |
|
$ |
14,806 |
|
$ |
16,599 |
|
For the purposes of determining pro forma net income, adjustments were made to actual net income of the Company for all periods presented in the table above. The pro forma net income assumes that amortization of acquired intangible assets began at the beginning of 2014 rather than on February 11, 2015. The result is a net increase in amortization expense of $0.1 million and $0.2 million for the three and six months ended June 28, 2014, respectively. Transaction costs totaling $0.4 million, which were incurred prior to the closing of the acquisition, are excluded from pro forma net income.
NOTE 4 MARKETABLE SECURITIES
All marketable securities of the Company were classified as available for sale and were recorded at market value using the specific identification method, and unrealized gains and losses are reflected in accumulated other comprehensive loss in the accompanying consolidated balance sheets. The aggregate fair value of available for sale securities and the aggregate amount of unrealized gains and losses in available for sale securities at July 4, 2015 were as follows:
|
|
Aggregate |
|
Aggregate Amount of |
| |||||
(In thousands) |
|
Fair Value |
|
Gains |
|
Losses |
| |||
Money market funds |
|
$ |
6 |
|
$ |
|
|
$ |
|
|
The aggregate fair value of available for sale securities and the aggregate amount of unrealized gains and losses in available for sale securities at January 3, 2015 were as follows:
|
|
Aggregate |
|
Aggregate Amount of |
| |||||
(In thousands) |
|
Fair Value |
|
Gains |
|
Losses |
| |||
Money market funds |
|
$ |
7 |
|
$ |
|
|
$ |
|
|
Certificates of deposit |
|
50 |
|
|
|
|
| |||
|
|
$ |
57 |
|
$ |
|
|
$ |
|
|
Money market funds do not have a maturity date.
There were no gross realized gains and losses for the three and six months ended July 4, 2015 or June 28, 2014.
NOTE 5 FAIR VALUE MEASUREMENTS
Accounting Standards Codification (ASC) 820-10, Fair Value Measurements, requires that for any assets and liabilities stated at fair value on a recurring basis in the Companys financial statements, the fair value of such assets and liabilities be measured based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Level 1 asset and liability values are derived from quoted prices in active markets for identical assets and liabilities and Level 2 asset and liability values are derived from quoted prices in inactive markets or based on other observable inputs.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
The Companys assets and liabilities measured at fair value on a recurring basis are categorized in the table below based upon their level within the fair value hierarchy as of July 4, 2015.
|
|
|
|
Fair Value Measurements at Reporting Date Using |
| ||||||||
(In thousands) |
|
|
|
Quoted Prices in |
|
Significant Other |
|
Significant |
| ||||
Description |
|
July 4, 2015 |
|
(Level 1) |
|
(Level 2) |
|
(Level 3) |
| ||||
Assets: |
|
|
|
|
|
|
|
|
| ||||
Restricted Cash |
|
$ |
1,259 |
|
$ |
1,259 |
|
$ |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Marketable securities: |
|
|
|
|
|
|
|
|
| ||||
Money market funds |
|
6 |
|
6 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Derivative assets: |
|
|
|
|
|
|
|
|
| ||||
Option contracts |
|
413 |
|
|
|
413 |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Funds in investments and other assets: |
|
|
|
|
|
|
|
|
| ||||
Israeli pension funds |
|
12,183 |
|
|
|
12,183 |
|
|
| ||||
Group insurance contracts |
|
5,879 |
|
|
|
5,879 |
|
|
| ||||
|
|
18,062 |
|
|
|
18,062 |
|
|
| ||||
|
|
$ |
19,740 |
|
$ |
1,265 |
|
$ |
18,475 |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Liabilities: |
|
|
|
|
|
|
|
|
| ||||
Derivative liabilities: |
|
|
|
|
|
|
|
|
| ||||
Option contracts |
|
83 |
|
|
|
83 |
|
|
|
The Companys assets and liabilities measured at fair value on a recurring basis are categorized in the table below based upon their level within the fair value hierarchy as of January 3, 2015.
|
|
|
|
Fair Value Measurements at Reporting Date Using |
| ||||||||
(In thousands) |
|
|
|
Quoted Prices in |
|
Significant Other |
|
Significant |
| ||||
Description |
|
January 3, 2015 |
|
(Level 1) |
|
(Level 2) |
|
(Level 3) |
| ||||
Assets: |
|
|
|
|
|
|
|
|
| ||||
Restricted Cash |
|
$ |
1,704 |
|
$ |
1,704 |
|
$ |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Marketable securities: |
|
|
|
|
|
|
|
|
| ||||
Money market funds |
|
7 |
|
7 |
|
|
|
|
| ||||
Certificates of deposit |
|
50 |
|
|
|
50 |
|
|
| ||||
|
|
57 |
|
7 |
|
50 |
|
|
| ||||
Derivative assets: |
|
|
|
|
|
|
|
|
| ||||
Option contracts |
|
103 |
|
|
|
103 |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Funds in investments and other assets: |
|
|
|
|
|
|
|
|
| ||||
Israeli pension funds |
|
11,090 |
|
|
|
11,090 |
|
|
| ||||
Group insurance contracts |
|
6,140 |
|
|
|
6,140 |
|
|
| ||||
|
|
17,230 |
|
|
|
17,230 |
|
|
| ||||
|
|
$ |
19,094 |
|
$ |
1,711 |
|
$ |
17,383 |
|
$ |
|
|
Liabilities: |
|
|
|
|
|
|
|
|
| ||||
Derivative liabilities: |
|
|
|
|
|
|
|
|
| ||||
Option contracts |
|
$ |
921 |
|
$ |
|
|
$ |
921 |
|
$ |
|
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
The Companys other financial instruments include short-term borrowings and long-term debt. The fair value of these financial instruments was estimated based on current rates for similar issues or on the current rates offered to the Company for debt of similar remaining maturities. The estimated fair values of these financial instruments were as follows:
|
|
July 4, 2015 |
|
January 3, 2015 |
| ||||||||
|
|
Carrying |
|
|
|
Carrying |
|
|
| ||||
(In thousands) |
|
Amount |
|
Fair Value |
|
Amount |
|
Fair Value |
| ||||
Short-term borrowings |
|
$ |
4,084 |
|
$ |
4,085 |
|
$ |
3,772 |
|
$ |
3,772 |
|
Long-term debt |
|
$ |
76,256 |
|
$ |
74,707 |
|
$ |
71,000 |
|
$ |
69,761 |
|
NOTE 6 SUPPLEMENTAL BALANCE SHEET INFORMATION
Inventories
Inventories that are expected to be sold within one year are classified as current inventories and are included in inventories in the accompanying consolidated balance sheets. Such inventories were as follows:
|
|
July 4, |
|
January 3, |
| ||
(In thousands) |
|
2015 |
|
2015 |
| ||
Raw materials and purchased parts |
|
$ |
75,796 |
|
$ |
68,989 |
|
Work in process |
|
19,360 |
|
16,564 |
| ||
Finished goods |
|
30,052 |
|
26,887 |
| ||
Short-term inventories |
|
$ |
125,208 |
|
$ |
112,440 |
|
Inventories that are not expected to be sold within one year are classified as long-term inventories and are included in investments and other assets in the accompanying consolidated balance sheets. Such inventories were as follows:
|
|
July 4, |
|
January 3, |
| ||
(In thousands) |
|
2015 |
|
2015 |
| ||
Raw materials and purchased parts |
|
$ |
2,271 |
|
$ |
3,208 |
|
Finished goods |
|
2,971 |
|
3,856 |
| ||
Long-term inventories |
|
$ |
5,242 |
|
$ |
7,064 |
|
Accrued Warranty Obligations
Unless otherwise stated in the Companys product literature or in its agreements with customers, products sold by the Companys Photonics and Optics Groups generally carry a one-year warranty from the original invoice date on all product materials and workmanship, other than filters and gratings products, which generally carry a 90-day warranty, and laser beam profilers and dental CAD/CAM scanners, which generally carry a two-year warranty. Products sold by the Photonics and Optics Groups to original equipment manufacturer (OEM) customers carry warranties generally ranging from 15 to 19 months. Products sold by the Companys Lasers Group carry warranties that vary by product and product component, but generally range from 90 days to two years. In certain cases, such warranties for Lasers Group products are limited by either a set time period or a maximum amount of hourly usage of the product, whichever occurs first. Defective products will be either repaired or replaced, generally at the Companys option, upon meeting certain criteria. The Company accrues a provision for the estimated costs that may be incurred for warranties relating to a product (based on historical experience) as a component of cost of sales. Short-term accrued warranty obligations, which expire within one year, are included in accrued expenses and other current liabilities and long-term warranty obligations are included in other long-term liabilities in the accompanying consolidated balance sheets.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
The activity in accrued warranty obligations was as follows:
|
|
Six Months Ended |
| ||||
|
|
July 4, |
|
June 28, |
| ||
(In thousands) |
|
2015 |
|
2014 |
| ||
Balance at beginning of year |
|
$ |
3,556 |
|
$ |
3,285 |
|
Additions charged to cost of sales |
|
1,591 |
|
1,496 |
| ||
Warranty claims |
|
(1,692 |
) |
(1,587 |
) | ||
Balance at end of period |
|
$ |
3,455 |
|
$ |
3,194 |
|
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities were as follows:
|
|
July 4, |
|
January 3, |
| ||
(In thousands) |
|
2015 |
|
2015 |
| ||
Deferred revenue |
|
$ |
13,681 |
|
$ |
13,032 |
|
Deferred lease liability |
|
4,852 |
|
5,094 |
| ||
Accrued income taxes |
|
996 |
|
2,219 |
| ||
Short-term accrued warranty obligations |
|
3,253 |
|
3,324 |
| ||
Other |
|
9,358 |
|
8,128 |
| ||
|
|
$ |
32,140 |
|
$ |
31,797 |
|
Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss consisted of the following:
|
|
July 4, |
|
January 3, |
| ||
(In thousands) |
|
2015 |
|
2015 |
| ||
Cumulative foreign currency translation losses |
|
$ |
(20,519 |
) |
$ |
(14,556 |
) |
Unrecognized net pension losses, net of tax |
|
(4,426 |
) |
(4,855 |
) | ||
Unrealized gains on investments and marketable securities, net of tax |
|
1,320 |
|
1,429 |
| ||
|
|
$ |
(23,625 |
) |
$ |
(17,982 |
) |
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
NOTE 7 GOODWILL AND INTANGIBLE ASSETS
The changes in the carrying amounts of goodwill were as follows:
|
|
Photonics |
|
Lasers |
|
Optics |
|
|
| ||||
(In thousands) |
|
Group |
|
Group |
|
Group |
|
Total |
| ||||
Balance at January 3, 2015: |
|
|
|
|
|
|
|
|
| ||||
Goodwill |
|
98,808 |
|
129,761 |
|
41,314 |
|
269,883 |
| ||||
Accumulated impairment losses |
|
(47,458 |
) |
(104,562 |
) |
(20,339 |
) |
(172,359 |
) | ||||
|
|
51,350 |
|
25,199 |
|
20,975 |
|
97,524 |
| ||||
Goodwill allocated to acquisition |
|
|
|
6,681 |
|
|
|
6,681 |
| ||||
Foreign currency impact |
|
|
|
(456 |
) |
|
|
(456 |
) | ||||
Balance at July 4, 2015: |
|
|
|
|
|
|
|
|
| ||||
Goodwill |
|
98,808 |
|
135,986 |
|
41,314 |
|
276,108 |
| ||||
Accumulated impairment losses |
|
(47,458 |
) |
(104,562 |
) |
(20,339 |
) |
(172,359 |
) | ||||
|
|
$ |
51,350 |
|
$ |
31,424 |
|
$ |
20,975 |
|
$ |
103,749 |
|
As of July 4, 2015, acquisition related intangible assets were as follows:
|
|
Amortization |
|
Gross |
|
Accumulated |
|
Carrying |
| |||
(In thousands) |
|
Period |
|
Value |
|
Amortization |
|
Value |
| |||
Intangible assets subject to amortization: |
|
|
|
|
|
|
|
|
| |||
Developed technology |
|
10-20 years |
|
$ |
39,815 |
|
$ |
(10,974 |
) |
$ |
28,841 |
|
Customer relationships |
|
up to 10 years |
|
28,677 |
|
(19,806 |
) |
8,871 |
| |||
In-process research and development |
|
10 years |
|
15,135 |
|
(1,879 |
) |
13,256 |
| |||
Other |
|
3 months-10 years |
|
2,202 |
|
(1,204 |
) |
998 |
| |||
|
|
|
|
85,829 |
|
(33,863 |
) |
51,966 |
| |||
Intangible assets not subject to amortization: |
|
|
|
|
|
|
|
|
| |||
Trademarks and trade names |
|
|
|
18,305 |
|
|
|
18,305 |
| |||
Intangible assets |
|
|
|
$ |
104,134 |
|
$ |
(33,863 |
) |
$ |
70,271 |
|
As of July 4, 2015, the gross values and accumulated amortization shown in the table above for intangible assets subject to amortization exclude amounts related to the Companys acquisition of Spectra-Physics, Inc. (and certain related entities), as the purchased intangible assets related to that acquisition have been fully amortized.
As of January 3, 2015, acquisition related intangible assets were as follows:
|
|
Amortization |
|
Gross |
|
Accumulated |
|
Carrying |
| |||
(In thousands) |
|
Period |
|
Value |
|
Amortization |
|
Value |
| |||
Intangible assets subject to amortization: |
|
|
|
|
|
|
|
|
| |||
Developed technology |
|
10-20 years |
|
$ |
45,646 |
|
$ |
(16,782 |
) |
$ |
28,864 |
|
Customer relationships |
|
up to 10 years |
|
47,827 |
|
(37,312 |
) |
10,515 |
| |||
In-process research and development |
|
10 years |
|
13,461 |
|
(1,496 |
) |
11,965 |
| |||
Other |
|
3 months-10 years |
|
7,461 |
|
(6,299 |
) |
1,162 |
| |||
|
|
|
|
114,395 |
|
(61,889 |
) |
52,506 |
| |||
Intangible assets not subject to amortization: |
|
|
|
|
|
|
|
|
| |||
Trademarks and trade names |
|
|
|
18,305 |
|
|
|
18,305 |
| |||
Intangible assets |
|
|
|
$ |
132,700 |
|
$ |
(61,889 |
) |
$ |
70,811 |
|
Amortization expense related to intangible assets totaled $2.1 million and $2.4 million for the three months ended July 4, 2015 and June 28, 2014, respectively, and $4.2 million and $4.9 million for the six months ended July 4, 2015 and June 28, 2014, respectively.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
Estimated aggregate amortization expense for future fiscal years is as follows:
(In thousands) |
|
Estimated |
| |
2015 (remaining) |
|
$ |
4,178 |
|
2016 |
|
7,837 |
| |
2017 |
|
6,689 |
| |
2018 |
|
4,525 |
| |
2019 |
|
3,934 |
| |
Thereafter |
|
17,500 |
| |
|
|
$ |
44,663 |
|
The Company has excluded $7.3 million of estimated amortization expense related to certain in-process research and development from the table above, as it was uncertain as of July 4, 2015 when the technology will be completed and when the amortization will begin.
NOTE 8 INTEREST AND OTHER EXPENSE, NET
Interest and other expense, net, was as follows:
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
(In thousands) |
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
| ||||
Interest expense |
|
$ |
(573 |
) |
$ |
(595 |
) |
$ |
(1,138 |
) |
$ |
(1,256 |
) |
Interest and dividend income |
|
27 |
|
69 |
|
68 |
|
123 |
| ||||
Derivative gain, net |
|
658 |
|
137 |
|
533 |
|
125 |
| ||||
Bank and portfolio asset management fees |
|
(339 |
) |
(266 |
) |
(693 |
) |
(526 |
) | ||||
Other expense, net |
|
(837 |
) |
(3 |
) |
(737 |
) |
(100 |
) | ||||
|
|
$ |
(1,064 |
) |
$ |
(658 |
) |
$ |
(1,967 |
) |
$ |
(1,634 |
) |
NOTE 9 STOCK-BASED COMPENSATION
During the six months ended July 4, 2015, the Company granted 0.5 million restricted stock units and 0.5 million stock-settled stock appreciation rights with weighted average grant date fair values of $19.11 and $7.62, respectively.
The total stock-based compensation expense included in the Companys consolidated statements of income and comprehensive income was as follows:
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
(In thousands) |
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
| ||||
Cost of sales |
|
$ |
285 |
|
$ |
279 |
|
$ |
681 |
|
$ |
491 |
|
Selling, general and administrative expenses |
|
2,126 |
|
2,465 |
|
5,322 |
|
4,301 |
| ||||
Research and development expense |
|
332 |
|
366 |
|
824 |
|
655 |
| ||||
|
|
$ |
2,743 |
|
$ |
3,110 |
|
$ |
6,827 |
|
$ |
5,447 |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
At July 4, 2015, the total compensation cost related to unvested stock-based awards granted to employees, officers and directors under the Companys stock-based benefit plans that had not yet been recognized was $20.7 million, net of estimated forfeitures. This future compensation expense will be amortized over a weighted-average period of 2.1 years using the straight-line attribution method. The actual compensation expense that the Company will recognize in the future related to unvested stock-based awards outstanding at July 4, 2015 will be adjusted for actual forfeitures and will be adjusted based on the Companys determination as to the extent to which performance conditions applicable to any stock-based awards have been or will be achieved.
At July 4, 2015, the Companys outstanding and exercisable stock options and stock appreciation rights, and the weighted average exercise price or base value, the weighted average remaining contractual life and the aggregate intrinsic value thereof, were as follows:
|
|
|
|
Weighted |
|
|
|
|
| ||
|
|
|
|
Average |
|
Weighted |
|
|
| ||
|
|
|
|
Exercise |
|
Average |
|
Aggregate |
| ||
|
|
Number of |
|
Price or |
|
Remaining |
|
Intrinsic |
| ||
|
|
Shares |
|
Base |
|
Contractual |
|
Value |
| ||
|
|
(In thousands) |
|
Value |
|
Life (Years) |
|
(In thousands) |
| ||
Stock options outstanding and exercisable |
|
34 |
|
$ |
13.78 |
|
0.5 |
|
$ |
170 |
|
Stock appreciation rights outstanding |
|
2,370 |
|
$ |
15.62 |
|
4.7 |
|
$ |
7,661 |
|
Stock appreciation rights exercisable |
|
1,336 |
|
$ |
13.89 |
|
3.5 |
|
$ |
6,532 |
|
NOTE 10 DEBT AND LINES OF CREDIT
Total short-term borrowings were as follows:
|
|
July 4, |
|
January 3, |
| ||
(In thousands) |
|
2015 |
|
2015 |
| ||
Japanese revolving lines of credit |
|
$ |
3,081 |
|
$ |
3,163 |
|
Japanese receivables financing facilities |
|
706 |
|
25 |
| ||
Israeli loans due October 2015 |
|
297 |
|
584 |
| ||
Total short-term borrowings |
|
$ |
4,084 |
|
$ |
3,772 |
|
Total long-term debt was as follows:
|
|
July 4, |
|
January 3, |
| ||
(In thousands) |
|
2015 |
|
2015 |
| ||
U.S. revolving line of credit expiring July 2018 |
|
$ |
76,000 |
|
$ |
71,000 |
|
Austrian loans due through March 2019 |
|
256 |
|
|
| ||
|
|
$ |
76,256 |
|
$ |
71,000 |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
NOTE 11 NET INCOME PER SHARE
The following table sets forth the computation of basic and diluted net income per share:
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
(In thousands, except per share data) |
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net income attributable to Newport Corporation |
|
$ |
5,770 |
|
$ |
8,952 |
|
$ |
14,434 |
|
$ |
16,838 |
|
|
|
|
|
|
|
|
|
|
| ||||
Shares: |
|
|
|
|
|
|
|
|
| ||||
Weighted average shares outstanding - basic |
|
39,717 |
|
39,881 |
|
39,659 |
|
39,703 |
| ||||
Dilutive potential common shares, using treasury stock method |
|
548 |
|
647 |
|
753 |
|
810 |
| ||||
Weighted average shares outstanding - diluted |
|
40,265 |
|
40,528 |
|
40,412 |
|
40,513 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net income per share attributable to Newport Corporation: |
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
0.15 |
|
$ |
0.22 |
|
$ |
0.36 |
|
$ |
0.42 |
|
Diluted |
|
$ |
0.14 |
|
$ |
0.22 |
|
$ |
0.36 |
|
$ |
0.42 |
|
For the three and six months ended July 4, 2015, 1.0 million stock appreciation rights, and for the three and six months ended June 28, 2014, an aggregate of 0.7 million stock options and stock appreciation rights, were excluded from the computations of diluted net income per share, as their inclusion would have been antidilutive. For the three and six months ended July 4, 2015, 0.5 million performance-based restricted stock units, and for the three and six months ended June 28, 2014, 0.6 million performance-based restricted stock units, were excluded from the computations of diluted net income per share, as the performance criteria for their vesting had not been met as of the end of such periods.
NOTE 12 INCOME TAXES
Income tax expense for each of the three and six months ended July 4, 2015 and June 28, 2014 consisted of a provision for federal, state and foreign taxes based on the annual estimated effective tax rate applicable to the Company, adjusted for items which are considered discrete to a particular period. The effective tax rates for the three and six months ended July 4, 2015 were 35.9% and 33.6%, respectively, and the effective tax rates for the three and six months ended June 28, 2014 were 29.9% and 30.5%, respectively.
The effective tax rates for the three and six months ended July 4, 2015 were unfavorably impacted by increased losses in jurisdictions in which the Company has recorded a full valuation allowance and, therefore, no current tax benefit may be realized. The effective tax rate for the six months ended July 4, 2015 was also unfavorably impacted by the passage of Japanese Tax Reform on March 31, 2015, which lowered long-term corporate tax rates. This necessitated a corresponding write down of deferred tax assets applicable to the Companys Japanese locations.
NOTE 13 STOCKHOLDERS EQUITY TRANSACTIONS
In May 2008, the Board of Directors of the Company approved a share repurchase program, authorizing the purchase of up to 4.0 million shares of the Companys common stock. During the six months ended July 4, 2015, the Company repurchased 0.6 million shares for a total of $12.1 million under this program. As of July 4, 2015, 2.7 million shares remained available for purchase under the program.
During the six months ended July 4, 2015, the Company cancelled 0.2 million shares of common stock underlying restricted stock units in payment by employees of taxes owed upon the vesting of restricted stock units issued to them under the Companys stock incentive plans. The value of these restricted stock units totaled $3.4 million at the time they were cancelled.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
NOTE 14 DEFINED BENEFIT PENSION PLANS
The Company has defined benefit pension plans covering substantially all full-time employees in France, Germany, Israel and Japan. In addition, the Company has certain pension liabilities relating to former employees of the Company in the United Kingdom. The Companys German plan is unfunded, as permitted under the plan and applicable laws. For financial reporting purposes, the calculation of net periodic pension costs is based upon a number of actuarial assumptions, including a discount rate for plan obligations, an assumed rate of return on pension plan assets and an assumed rate of compensation increase for employees covered by the plan. All of these assumptions are based upon managements judgment, considering all known trends and uncertainties. Actual results that differ from these assumptions would impact future expense recognition and the cash funding requirements of the Companys pension plans.
Net periodic benefit costs for the plans in aggregate included the following components:
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
(In thousands) |
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
| ||||
Service cost |
|
$ |
803 |
|
$ |
1,047 |
|
$ |
1,302 |
|
$ |
1,260 |
|
Interest cost on benefit obligations |
|
120 |
|
114 |
|
241 |
|
316 |
| ||||
Expected return on plan assets |
|
(44 |
) |
(71 |
) |
(87 |
) |
(141 |
) | ||||
Amortization of net loss |
|
91 |
|
45 |
|
182 |
|
90 |
| ||||
|
|
$ |
970 |
|
$ |
1,135 |
|
$ |
1,638 |
|
$ |
1,525 |
|
NOTE 15 BUSINESS SEGMENT INFORMATION
The operating segments reported below are the segments of the Company for which separate financial information is available and for which operating results are evaluated regularly by the Chief Executive Officer, who is the chief operating decision maker, in deciding how to allocate resources and in assessing performance. The Company develops, manufactures and markets its products within three distinct business segments: its Photonics Group, its Lasers Group and its Optics Group.
The Company measured income reported for each operating segment, which included only those costs that were directly attributable to the operations of that segment, and excluded unallocated operating expenses, such as corporate overhead and intangible asset amortization, certain gains and losses, interest and other expense, net, and income taxes.
(In thousands) |
|
Photonics |
|
Lasers |
|
Optics |
|
Total |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Three months ended July 4, 2015: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
61,701 |
|
$ |
44,496 |
|
$ |
41,780 |
|
$ |
147,977 |
|
Segment income |
|
$ |
15,277 |
|
$ |
1,041 |
|
$ |
4,975 |
|
$ |
21,293 |
|
|
|
|
|
|
|
|
|
|
| ||||
Three months ended June 28, 2014: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
63,466 |
|
$ |
47,113 |
|
$ |
42,653 |
|
$ |
153,232 |
|
Segment income |
|
$ |
14,400 |
|
$ |
6,148 |
|
$ |
4,989 |
|
$ |
25,537 |
|
|
|
|
|
|
|
|
|
|
| ||||
Six months ended July 4, 2015: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
125,939 |
|
$ |
94,355 |
|
$ |
84,338 |
|
$ |
304,632 |
|
Segment income |
|
$ |
32,429 |
|
$ |
6,665 |
|
$ |
9,635 |
|
$ |
48,729 |
|
|
|
|
|
|
|
|
|
|
| ||||
Six months ended June 28, 2014: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
122,936 |
|
$ |
93,587 |
|
$ |
83,599 |
|
$ |
300,122 |
|
Segment income |
|
$ |
27,946 |
|
$ |
11,728 |
|
$ |
9,545 |
|
$ |
49,219 |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
July 4, 2015
The following table reconciles segment income to consolidated income before income taxes:
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
(In thousands) |
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
| ||||
Segment income |
|
$ |
21,293 |
|
$ |
25,537 |
|
$ |
48,729 |
|
$ |
49,219 |
|
Unallocated operating expenses |
|
(11,222 |
) |
(12,052 |
) |
(23,941 |
) |
(23,619 |
) | ||||
(Loss) gain on disposal of assets |
|
|
|
|
|
(1,088 |
) |
411 |
| ||||
Interest and other expense, net |
|
(1,064 |
) |
(658 |
) |
(1,967 |
) |
(1,634 |
) | ||||
|
|
$ |
9,007 |
|
$ |
12,827 |
|
$ |
21,733 |
|
$ |
24,377 |
|
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Managements Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our unaudited consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and in conjunction with our Annual Report on Form 10-K for the year ended January 3, 2015 previously filed with the SEC. This discussion contains descriptions of our expectations regarding future trends affecting our business. Words such as anticipate, believe, can, continue, could, estimate, expect, intend, may, plan, potential, predict, should, will, would, or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance or condition, trends in our business, or other characterizations of future events or circumstances are forward-looking statements. These forward-looking statements and other forward-looking statements made elsewhere in this report are made in reliance upon safe harbor provisions in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of several factors, including, but not limited to those factors set forth and discussed in Item 1 (Business) and Item 1A (Risk Factors) of Part I, and Item 7 (Managements Discussion and Analysis of Financial Condition and Results of Operations) of Part II, of our Annual Report on Form 10-K for the year ended January 3, 2015. In light of the significant uncertainties inherent in the forward-looking information included in this report, the inclusion of this information should not be regarded as a representation by us or any other person that our objectives or plans will be achieved and readers are cautioned not to place undue reliance on such forward-looking information. Except as required by law, we undertake no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
Overview
We are a global supplier of advanced-technology products and systems, including lasers, photonics instrumentation, precision positioning and vibration isolation products and systems, optical components, subassemblies and subsystems, and three-dimensional non-contact measurement equipment. Our products are used worldwide in a variety of industries, including scientific research, defense and security, microelectronics, life and health sciences and industrial markets. We operate within three distinct business segments: our Photonics Group, our Lasers Group and our Optics Group. All of these groups offer a broad array of advanced technology products and services to original equipment manufacturer (OEM) and end-user customers across a wide range of applications in all of our targeted end markets.
The following is a discussion and analysis of certain factors that have affected our results of operations and financial condition during the periods included in the accompanying unaudited consolidated financial statements.
Acquisition of FEMTOLASERS
On February 11, 2015, we acquired all of the capital stock of FEMTOLASERS Produktions GmbH (FEMTOLASERS). The initial purchase price of 9.1 million was paid in cash at closing and is subject to a net asset adjustment. Based on the preliminary financial information provided by FEMTOLASERS, we estimated an initial net asset adjustment to the purchase price of approximately 1.6 million during the first quarter of 2015. Based on additional information obtained during the second quarter, we estimated a revised net asset adjustment of 2.1 million, resulting in a purchase price of 7.0 million (approximately $7.9 million). The final amount of this net asset adjustment is subject to agreement between us and the FEMTOLASERS selling shareholders, which we expect to finalize during the second half of 2015. Of the initial purchase price, 2.3 million was deposited at closing into escrow until thirty months after closing, to secure certain obligations of the FEMTOLASERS selling shareholders under the share purchase agreement, including the net asset adjustment. We incurred $0.4 million in transaction costs, which have been expensed as incurred and are included in selling, general and administrative expenses in the statements of income and comprehensive income. FEMTOLASERS expands our offering of ultrafast laser products and enhances our technology base in this area. The results of FEMTOLASERS have been included in the results of our Lasers Group as of the acquisition date.
Immediately following the closing of the acquisition, we repaid 3.6 million (approximately $4.0 million) of FEMTOLASERS outstanding loans that were assumed as part of the acquisition.
Results of Operations for the Three and Six Months Ended July 4, 2015 and June 28, 2014
The following table presents our results of operations for the periods indicated as a percentage of net sales:
|
|
Percentage of Net Sales |
| ||||||
|
|
Three Months Ended |
|
Six Months Ended |
| ||||
|
|
July 4, |
|
June 28, |
|
July 4, |
|
June 28, |
|
|
|
2015 |
|
2014 |
|
2015 |
|
2014 |
|
Net sales |
|
100.0 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
Cost of sales |
|
56.8 |
|
54.4 |
|
55.9 |
|
54.9 |
|
Gross profit |
|
43.2 |
|
45.6 |
|
44.1 |
|
45.1 |
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
26.2 |
|
27.5 |
|
26.0 |
|
27.1 |
|
Research and development expense |
|
10.2 |
|
9.3 |
|
9.9 |
|
9.5 |
|
Loss (gain) on sale of assets |
|
|
|
|
|
0.4 |
|
(0.1 |
) |
Operating income |
|
6.8 |
|
8.8 |
|
7.8 |
|
8.6 |
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net |
|
(0.7 |
) |
(0.4 |
) |
(0.7 |
) |
(0.5 |
) |
Income before income taxes |
|
6.1 |
|
8.4 |
|
7.1 |
|
8.1 |
|
|
|
|
|
|
|
|
|
|
|
Income tax provision |
|
2.2 |
|
2.5 |
|
2.4 |
|
2.5 |
|
Net income |
|
3.9 |
|
5.9 |
|
4.7 |
|
5.6 |
|
Net income attributable to non-controlling interests |
|
|
|
0.0 |
|
|
|
0.0 |
|
Net income attributable to Newport Corporation |
|
3.9 |
% |
5.9 |
% |
4.7 |
% |
5.6 |
% |
Net Sales
Each of our operating groups sells products to customers in a wide range of industries, which we categorize into five key end markets: scientific research market; defense and security markets; microelectronics market; life and health sciences market; and industrial manufacturing and other end markets. The tables below reflect our net sales for the three and six months ended July 4, 2015 and June 28, 2014, by operating group and by key end market.
Sales by Operating Group
|
|
Three Months Ended |
|
|
|
|
| |||||
(In thousands) |
|
July 4, |
|
June 28, |
|
Decrease |
|
Percentage |
| |||
Photonics Group |
|
$ |
61,701 |
|
$ |
63,466 |
|
$ |
(1,765 |
) |
(2.8 |
)% |
Lasers Group |
|
44,496 |
|
47,113 |
|
(2,617 |
) |
(5.6 |
) | |||
Optics Group |
|
41,780 |
|
42,653 |
|
(873 |
) |
(2.0 |
) | |||
Total sales |
|
$ |
147,977 |
|
$ |
153,232 |
|
$ |
(5,255 |
) |
(3.4 |
)% |
|
|
Six Months Ended |
|
|
|
|
| |||||
(In thousands) |
|
July 4, |
|
June 28, |
|
Increase |
|
Percentage |
| |||
Photonics Group |
|
$ |
125,939 |
|
$ |
122,936 |
|
$ |
3,003 |
|
2.4 |
% |
Lasers Group |
|
94,355 |
|
93,587 |
|
768 |
|
0.8 |
| |||
Optics Group |
|
84,338 |
|
83,599 |
|
739 |
|
0.9 |
| |||
Total sales |
|
$ |
304,632 |
|
$ |
300,122 |
|
$ |
4,510 |
|
1.5 |
% |
Sales by End Market
|
|
Three Months Ended |
|
|
|
Percentage |
| |||||
(In thousands) |
|
July 4, |
|
June 28, |
|
Increase / |
|
Increase / |
| |||
Scientific research |
|
$ |
33,421 |
|
$ |
30,544 |
|
$ |
2,877 |
|
9.4 |
% |
Microelectronics |
|
38,948 |
|
40,869 |
|
(1,921 |
) |
(4.7 |
) | |||
Life and health sciences |
|
26,341 |
|
32,393 |
|
(6,052 |
) |
(18.7 |
) | |||
Defense and security |
|
15,073 |
|
14,481 |
|
592 |
|
4.1 |
| |||
Industrial manufacturing and other |
|
34,194 |
|
34,945 |
|
(751 |
) |
(2.1 |
) | |||
Total sales |
|
$ |
147,977 |
|
$ |
153,232 |
|
$ |
(5,255 |
) |
(3.4 |
)% |
|
|
|
|
|
|
|
| |||||
|
|
Six Months Ended |
|
|
|
Percentage |
| |||||
(In thousands) |
|
July 4, |
|
June 28, |
|
Increase / |
|
Increase / |
| |||
Scientific research |
|
$ |
68,786 |
|
$ |
62,425 |
|
$ |
6,361 |
|
10.2 |
% |
Microelectronics |
|
78,825 |
|
74,822 |
|